United Neuroscienceunsis A Clinical Stage Biotech Company Focused On Developing Innovative Therapies For Neurological Disordersthe Company Aims To Create Effective Treatments For Brain Related Conditions By Utilizing Advanced Technologies To Meet Significant Medical Needs Uns Specializes In Developing Vaccines That Stimulate The Body S Production Ofendobodiesagainst Proteins Linked To Neurological Diseasestheir Pipeline Includes Vaccines For Alzheimer S Diseasesuch As Ub 311Which Targets Beta Amyloid Plaques And Is Currently In Phase 2 Clinical Trialsthey Are Also Working On Ub 312 And A Vaccine Targeting Tau Proteinalong With Exploring Options For Migraineneuroinflammatory Conditionsneuropathic Painand Neuromuscular Dystrophies In April 2021United Neuroscience Merged With Covaxx To Form Vaxxinityinc Enhancing Their Capabilities In Vaccine Development For Both Chronic And Infectious Diseasesas A Subsidiary Of Vaxxinityuns Contributes To The Mission Of Advancing Health Through Innovative Vaccine Technologies
No conferences found for this company.
| Company Name | United Neuroscience Ltd |
| Country |
Ireland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
